Mandangan, Maybel .

HRN: 25-18-30  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2024
CEFUROXIME 500MG (TAB)
06/14/2024
06/20/2024
PO
1 Tab
BID X 7 Days
S/p NSVD, Thinly MSAF, RMLE With Episioraphy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: